Export Controls is a topic tracked in our intelligence system with 6 linked articles.
CAISI leadership turnover and US regulatory moves underscore AI governance risk, while Japan’s massive physical-AI investments and Nvidia-driven infrastructure signal a major, capex-heavy shift in AI deployment.
TechCrunch piece analyzes open-weight LLMs vs. closed models, regulatory risk in the US (potential bans on Chinese models, export controls, and new AI-safety governance) and implications for frontier labs and IPO timing.
DeepSeek is reportedly aiming to raise about $1.5B at a roughly $71B valuation with an IPO potential as early as late 2026, after a $7B funding round at a $50B valuation, with notable investors and exposure to U.S. export-control regulatory constraints.
Verity Harding argues the AI arms race framing hampers safety and equitable deployment, advocating international cooperation and a coalition of middle powers to counter nationalist tendencies and regulatory overreach.
US claims ASML’s top chip tool may be in China while ASML denies it, highlighting export-license regulatory risk for ASML.
US government export controls on Anthropic’s Fable 5/Mythos 5 forced offline usage and underscored a volatile regulatory regime with quick unilateral actions and potential industry-wide spillovers.
Subscribe for real-time topic updates and unlimited access to our intelligence platform.